Home Infusion Therapy Market Size, Share, Growth, and Industry Analysis, By Type (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infectives, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Others), Regional Insights and Forecast From 2026 To 2035

Home Infusion Therapy Market Overview

The global home infusion therapy market size is estimated at USD 26314.13 Million in 2026 and expected to rise to USD 43707.92 Million by 2035, experiencing a CAGR of 5.8% during the forecast from 2026 to 2035.

The home infusion therapy market is increasingly positioned within decentralized healthcare as patients receive intravenous drugs, biologics, fluids, and nutritional therapies outside institutional settings. Portable infusion pumps represent approximately 49.6% of product demand, supported by programmable delivery, compact designs, dose accuracy, and improved patient mobility. Anti-infective therapy remains a major home infusion application, accounting for approximately 31.2% of application demand. Market adoption is supported by chronic disease management, hospital discharge programs, specialty pharmaceutical pipelines, longer treatment requirements, and patient preference for home-based care. Connected infusion technology, remote patient monitoring, needleless systems, and improved vascular-access products are strengthening treatment safety and clinical oversight. (Mordor Intelligence)

The USA home infusion therapy market benefits from established specialty pharmacies, infusion providers, home healthcare agencies, hospital discharge networks, and insurance coverage structures. Medicare Part B covers qualifying home infusion equipment and supplies, including pumps, tubing, IV poles, and catheters, while qualifying professional services include nursing, patient education, caregiver training, and monitoring. The national supplier environment continues to expand through specialty pharmacy integration and provider partnerships. Home infusion is increasingly used for anti-infectives, immunoglobulins, nutritional support, hydration, specialty pharmaceuticals, and selected chemotherapy protocols. Portable pumps and remote monitoring platforms are improving treatment coordination while reducing dependence on repeated hospital-based administration. (Medicare)

Key Findings

• Market Size and Forecast: Home infusion therapy market stood at USD 26314.13 Million in 2026 and expected to rise to USD 43707.92 Million by 2035, experiencing a CAGR of 5.8% CAGR. 
• Type Leadership: Infusion pumps lead home infusion therapy products with 49.6% share, supported by portability, programmable dosing, reliability, and long-duration treatment adoption. (Mordor Intelligence)
• Application Leadership: Anti-infectives command 31.2% market share, supported by prolonged antibiotic administration, hospital discharge programs, infection management, and home-based intravenous treatment. (Mordor Intelligence)
• Key Company Landscape: Baxter and B. Braun maintain prominent positions through extensive infusion portfolios, pump technologies, consumables, clinical capabilities, and international distribution networks. (Grand View Research)
• Fastest Growing Region: North America holds approximately 42.6% market share, while Asia records stronger expansion through healthcare infrastructure development and aging populations. (Straits Research)
• Key Trends: Portable pumps represent 49.6% of product demand as connected monitoring, specialty biologics, home healthcare expansion, and infusion safety technologies reshape treatment delivery. (Mordor Intelligence)

Home Infusion Therapy Market Latest Trends

The home infusion therapy market is shifting toward portable, digitally connected, and patient-centered drug delivery systems. Infusion pumps remain central to this transformation, representing approximately 49.6% of product demand. Lightweight ambulatory pumps enable patients receiving anti-infectives, hydration therapy, chemotherapy, parenteral nutrition, and specialty pharmaceuticals to maintain greater mobility while continuing prescribed treatment at home. Manufacturers are emphasizing programmable dosing, dose-error reduction, alarm management, flow accuracy, battery efficiency, and simplified interfaces.

Remote monitoring is another important home infusion therapy market trend. Connected platforms allow healthcare professionals to review treatment progress, identify device-related issues, support adherence, and coordinate nursing interventions without requiring continuous institutional supervision. Needleless connectors and improved IV cannulas are receiving increased attention because infection prevention and vascular-access safety remain critical during repeated infusion procedures.

Anti-infective therapy accounts for approximately 31.2% of application demand, reflecting extensive use of intravenous antibiotics following hospital discharge. Specialty pharmaceutical administration is also expanding as injectable biologics become suitable for supervised home use. Home infusion providers are consequently strengthening pharmacy, nursing, logistics, patient education, and cold-chain capabilities. These developments are creating opportunities for integrated infusion ecosystems combining devices, consumables, pharmaceuticals, digital monitoring, and clinical services. (Mordor Intelligence)

Home Infusion Therapy Market Dynamics

DRIVER

" Increasing transition from hospital-based infusion treatment toward home healthcare."

The principal home infusion therapy market driver is the continuing transition of appropriate intravenous and subcutaneous treatments from hospitals and outpatient facilities into patients’ homes. Chronic diseases, recurring infections, nutritional disorders, immune conditions, and long-duration pharmaceutical treatments create sustained requirements for infusion administration. Home-based delivery can improve patient convenience while supporting hospital discharge and continuity of care. Medicare coverage in the USA includes qualifying infusion equipment, supplies, professional services, caregiver education, and monitoring, demonstrating the established role of home infusion within healthcare delivery. The availability of portable pumps, reliable intravenous sets, IV cannulas, needleless connectors, and specialty pharmacy services further supports this transition. Clinical coordination among physicians, pharmacists, nurses, caregivers, and discharge planners is enabling increasingly complex therapies to be administered safely outside hospitals. (Medicare)

RESTRAINT

" Complex clinical administration and patient safety requirements."

Home infusion therapy requires careful clinical supervision because intravenous treatment involves vascular access, medication preparation, device operation, infection prevention, dose management, and adverse-event monitoring. These requirements can limit adoption among patients who lack sufficient caregiver assistance or appropriate home environments. Infusion pump programming errors, catheter complications, medication incompatibility, line contamination, and improper storage can create significant clinical risks. Consequently, providers must invest in nursing support, training, pharmacy coordination, monitoring protocols, and equipment maintenance. Medicare guidance recognizes nursing education, caregiver training, infusion-site assessment, dressing changes, and periodic monitoring as important components of home infusion delivery. Such requirements increase operational complexity for suppliers attempting to scale geographically. Maintaining standardized clinical practices across distributed patient populations remains particularly challenging when therapies involve specialty pharmaceuticals, parenteral nutrition, chemotherapy, or biologics requiring precise administration procedures. (CMS)

OPPORTUNITY

" Expansion of connected infusion devices and specialty pharmaceutical administration."

Connected infusion technology creates substantial opportunities within the home infusion therapy market by integrating drug delivery with remote monitoring, treatment documentation, adherence support, and clinical communication. Portable pumps can increasingly support sophisticated home treatment protocols while allowing healthcare professionals to maintain visibility over therapy progress. The opportunity extends beyond equipment manufacturers because specialty pharmacies, nursing providers, pharmaceutical companies, digital health developers, and home healthcare organizations can collaborate around integrated treatment models. Specialty pharmaceuticals represent an important expansion area as injectable biologics and complex therapies move toward decentralized administration. Approximately 49.6% of product demand is associated with infusion pumps, highlighting their importance within home infusion infrastructure. Future competitive differentiation will increasingly depend on device usability, interoperability, cybersecurity, dose accuracy, patient training, and data connectivity. Companies offering coordinated pumps, consumables, monitoring technologies, and clinical support can strengthen their positioning across long-duration home therapies. (Mordor Intelligence)

CHALLENGE

" Maintaining skilled nursing capacity and consistent treatment quality across decentralized care."

The home infusion therapy market faces an operational challenge in delivering standardized clinical quality across geographically dispersed patients. Successful home infusion depends on coordination among prescribing physicians, pharmacists, hospital discharge teams, health plans, infusion suppliers, nurses, patients, and caregivers. Skilled personnel must evaluate vascular access, teach device operation, monitor treatment response, manage dressing changes, identify complications, and reinforce medication protocols. USA monitoring data showed that 7 supplier organizations accounted for 54% of Medicare home infusion service visits during the latest measured 12-month period, indicating considerable concentration within qualified service delivery. Expanding treatment availability therefore requires broader nursing capacity, stronger logistics, standardized education, and reliable digital communication. Providers must simultaneously manage cold-chain products, infusion equipment, disposables, medication schedules, emergency procedures, and regulatory documentation, making scalable home infusion operations clinically and organizationally demanding. (CMS)

Home Infusion Therapy Market Segmentation

The home infusion therapy market is segmented by type into infusion pumps, intravenous sets, IV cannulas, and needleless connectors, while applications include anti-infectives, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and others. Infusion pumps constitute approximately 49.6% of product demand because controlled drug delivery is fundamental to numerous long-duration therapies. Anti-infectives represent approximately 31.2% of application demand, supported by intravenous antibiotic treatment following hospital discharge. Each segment addresses distinct requirements involving flow control, vascular access, infection prevention, nutrition delivery, specialty drug administration, and patient mobility. Increasing home healthcare utilization supports demand across both disposable and reusable infusion products. (Mordor Intelligence)

By Type

Based on Type the global market can be categorized in to Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors.

• Infusion Pumps: Infusion pumps represent the leading product category in the home infusion therapy market with approximately 49.6% market share. Their leadership reflects the requirement for controlled, accurate, and continuous administration across anti-infective treatment, chemotherapy, hydration, parenteral nutrition, specialty pharmaceuticals, and other home therapies. Portable and ambulatory designs are increasingly preferred because patients can receive prescribed medication without remaining continuously connected to stationary clinical equipment. Programmable infusion rates, alarm functions, battery operation, compact configurations, and dose-control capabilities strengthen adoption. Manufacturers are increasingly integrating connectivity and monitoring features that support decentralized clinical oversight. Pump reliability remains especially important for long-duration therapies requiring predictable administration schedules and precise delivery. (Mordor Intelligence)

• Intravenous Sets: Intravenous sets account for an estimated 24.4% share of the product segmentation used in this report. These consumables provide the essential fluid pathway connecting medication containers, infusion pumps, vascular-access devices, and patients. Demand is supported by repeated use across anti-infective therapy, hydration, chemotherapy, nutritional support, and specialty pharmaceutical administration. Home infusion providers require dependable tubing systems that support controlled flow, secure connections, compatibility with infusion pumps, and simplified handling by nurses or trained caregivers. Disposable intravenous sets also support infection-control protocols because components can be replaced according to clinical schedules. Product development increasingly focuses on closed-system designs, improved connector compatibility, reduced priming complexity, and configurations suited to portable infusion equipment used in decentralized care.

• IV Cannulas: IV cannulas hold an estimated 15.2% share within the product segmentation used throughout this report. Cannulas establish peripheral vascular access for medications, fluids, and other prescribed infusion therapies delivered within home settings. Their importance is particularly evident in hydration therapy, anti-infective treatment, and shorter-duration infusion procedures where peripheral access is clinically appropriate. Manufacturers continue to improve catheter materials, insertion characteristics, stabilization, visibility, and safety mechanisms. Home infusion providers prioritize cannulas that simplify placement while reducing unnecessary manipulation of vascular-access sites. Demand is influenced by treatment duration, patient vascular condition, prescribed medication, and nursing protocols. Appropriate cannula selection supports reliable administration while helping providers manage infiltration, dislodgement, and vascular-access complications.

• Needleless Connectors: Needleless connectors represent an estimated 10.8% market share within the product segmentation used in this report. These products provide access to intravenous lines without routine needle use, supporting safer medication administration and repeated connection procedures. Their role has expanded as home infusion therapy increasingly involves long-duration treatment requiring frequent line access by nurses, caregivers, or trained patients. Connector technologies focus on secure fluid pathways, simplified disinfection, reduced manipulation, and compatibility with multiple infusion systems. Infection prevention remains an important purchasing consideration because vascular-access contamination can interrupt treatment and create additional clinical intervention requirements. Needleless systems also support occupational safety by reducing unnecessary needle exposure during line access, medication connection, flushing, and disconnection procedures.

By Application

Based on Application the global market can be categorized in to Anti-Infectives, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Others.

• Anti-Infectives: Anti-infectives lead the home infusion therapy market application segmentation with 31.2% market share. Home intravenous antibiotic therapy supports patients requiring continued treatment after hospital discharge and patients whose clinical condition permits treatment outside institutional settings. Common treatment requirements include bacterial infections that need scheduled intravenous administration under physician and pharmacy supervision. Portable infusion pumps, intravenous sets, vascular-access devices, and nursing services enable prescribed antibiotic courses to continue at home. Anti-infective home infusion can reduce repeated facility visits while providing structured medication administration. Specialty pharmacies coordinate preparation, dispensing, storage instructions, delivery, and patient education. Increasing emphasis on appropriate hospital discharge and outpatient parenteral antimicrobial therapy supports continued utilization of this application.

• Endocrinology: Endocrinology accounts for an estimated 7.8% share of the home infusion therapy market application segmentation used throughout this report. The segment includes selected hormone-related and metabolic treatments requiring controlled administration and professional supervision outside traditional clinical environments. Home infusion models can support patients who require repeated therapy while reducing unnecessary facility visits. Programmable pumps provide controlled administration, while nursing support assists with device management, vascular access, patient education, and treatment monitoring. Increasing management of chronic endocrine and metabolic disorders supports demand for convenient treatment models. Manufacturers and providers are focusing on compact equipment, simplified interfaces, accurate dosing, and improved monitoring capabilities to support patients receiving recurring therapy in decentralized healthcare environments.

• Hydration Therapy: Hydration therapy represents an estimated 12.4% share of the home infusion therapy market application segmentation. Home hydration is used for clinically appropriate patients requiring intravenous fluid replacement without continuous hospitalization. Treatment may support patients experiencing dehydration associated with illness, treatment complications, gastrointestinal conditions, or other physician-determined requirements. Home infusion providers coordinate fluids, administration supplies, pumps when required, vascular-access management, and nursing supervision. Portable equipment enables treatment to occur while patients remain in familiar surroundings. Demand also benefits from broader hospital-at-home and post-discharge care strategies. Providers emphasize accurate fluid administration, sterile technique, electrolyte monitoring where applicable, and patient assessment because inappropriate fluid management can create complications requiring clinical intervention.

• Chemotherapy: Chemotherapy holds an estimated 8.6% share of the home infusion therapy market application segmentation used consistently in this report. Selected oncology medicines can be administered through ambulatory infusion systems when clinical protocols, medication characteristics, patient condition, and healthcare supervision permit home treatment. Portable pumps are particularly relevant for therapies requiring continuous administration following initiation in an oncology facility. Home-based components can reduce repeated time spent inside infusion centers while preserving scheduled treatment delivery. Safety requirements remain substantial because cytotoxic medications require controlled handling, precise dosing, secure connections, and adverse-event monitoring. Oncology providers, specialty pharmacies, infusion companies, and nurses therefore coordinate closely when treatment extends into the home. Advances in ambulatory pumps continue supporting this specialized application.

• Enteral Nutrition: Enteral nutrition accounts for an estimated 9.1% share of the application segmentation used in this home infusion therapy market report. This category supports patients who cannot obtain sufficient nutrition through normal oral intake but retain functioning gastrointestinal systems. Home enteral therapy uses feeding pumps, administration sets, tubing, and prescribed nutritional formulations to support scheduled delivery. Patients and caregivers require education concerning equipment operation, feeding schedules, hygiene, tube management, and troubleshooting. Portable feeding systems can improve mobility and make long-duration nutritional support more compatible with daily activities. Demand is influenced by neurological disorders, swallowing difficulties, gastrointestinal conditions, cancer care, and recovery requirements. Equipment manufacturers continue prioritizing accurate delivery, compact pump designs, simplified programming, and improved alarm functionality.

• Parenteral Nutrition: Parenteral nutrition represents an estimated 10.3% share of the home infusion therapy market application segmentation. This treatment provides nutrients intravenously when gastrointestinal intake cannot adequately satisfy patient requirements. Home parenteral nutrition is among the more clinically complex home infusion applications because therapy can involve central venous access, precise formulations, extended infusion periods, sterile handling, and close patient monitoring. Infusion pumps provide controlled administration while specialty pharmacies prepare individualized formulations according to prescriptions. Patients and caregivers require substantial training in line care, connection procedures, storage, pump operation, and complication recognition. Demand is supported by intestinal failure and other conditions requiring intravenous nutritional support. Reliable logistics and infection-control procedures remain fundamental to successful home administration.

• Specialty Pharmaceuticals: Specialty pharmaceuticals account for an estimated 14.2% share of the home infusion therapy market application segmentation used throughout this report. This segment is increasingly important as biologics, immunotherapies, immunoglobulins, enzyme therapies, and other complex medicines become suitable for supervised administration outside hospitals. Specialty pharmacy networks provide medication preparation, cold-chain management, insurance coordination, nursing services, patient education, and adherence support. Home delivery offers convenience for patients receiving recurring treatments while enabling healthcare systems to decentralize appropriate infusion services. Manufacturers are developing administration technologies designed for accurate dosing, simplified operation, and connectivity. Expansion of specialty drug pipelines is also encouraging partnerships among pharmaceutical manufacturers, infusion providers, healthcare organizations, and device companies seeking integrated home-treatment pathways.

• Others: Other applications represent an estimated 6.4% share of the home infusion therapy market application segmentation. This category incorporates therapies that do not fall directly within the major defined applications but remain suitable for physician-directed administration in home settings. Requirements can involve pain management, selected cardiovascular treatments, immune-related therapies, supportive medications, and other intravenous or subcutaneous treatments. Adoption depends on medication stability, administration complexity, patient suitability, insurance arrangements, nursing availability, and monitoring requirements. Home infusion providers evaluate each therapy carefully before transferring administration outside institutional settings. Advances in portable delivery equipment, remote monitoring, specialty pharmacy logistics, and patient training are increasing the number of treatments potentially compatible with decentralized care while maintaining appropriate clinical safeguards.

Home Infusion Therapy Market Regional Outlook

• North America

North America leads the home infusion therapy market with 42.6% market share, supported by established specialty pharmacies, sophisticated home healthcare networks, hospital discharge programs, and broad availability of infusion equipment. The USA represents the primary regional contributor because home infusion has become integrated with post-acute treatment and chronic disease management. Medicare covers qualifying home infusion equipment and supplies under defined circumstances, strengthening structured access to pumps, tubing, catheters, and related professional services.

The region also benefits from extensive adoption of specialty pharmaceuticals and biologics. An aging population increases requirements for chronic disease treatment and post-discharge support. Approximately 18% of the USA population was aged 65 or older in 2024, reinforcing demand for convenient healthcare delivery models. Home infusion providers continue investing in pharmacy capacity, nursing networks, remote monitoring, and cold-chain logistics. Canada additionally supports regional demand through established home healthcare programs and increasing use of ambulatory infusion technologies.

• Europe

Europe represents 27.4% of the global home infusion therapy market within the consistent regional framework used throughout this report. Regional adoption is supported by mature healthcare systems, aging populations, strong pharmaceutical manufacturing capabilities, and increasing emphasis on community-based treatment. Germany, France, the United Kingdom, Italy, and Spain represent important European markets for infusion equipment, nutritional therapy, anti-infective treatment, and specialty pharmaceuticals.

Approximately 21% of the European Union population was aged 65 or older in 2023, creating significant demand for chronic disease management and long-duration healthcare services. European providers increasingly use ambulatory infusion pumps and structured nursing support to enable appropriate patients to receive treatment outside hospitals. Medical device regulations emphasize safety, traceability, clinical performance, and post-market surveillance, influencing product development and procurement. Europe also benefits from established manufacturers such as B. Braun and Fresenius Kabi, which maintain extensive infusion technology portfolios and international distribution capabilities.

• Asia

Asia accounts for 21.0% of the global home infusion therapy market under the regional allocation maintained consistently throughout this report. Regional expansion is supported by population aging, healthcare infrastructure investment, growing chronic disease prevalence, expanding private healthcare networks, and increasing availability of specialty pharmaceuticals. Japan represents a mature home healthcare environment, while China and India provide substantial long-term opportunities because of their large patient populations and expanding hospital and pharmacy infrastructure.

Japan had approximately 29% of its population aged 65 or older in 2024, strengthening demand for decentralized healthcare and chronic treatment services. China continues expanding healthcare capacity and digital health adoption, creating opportunities for connected infusion equipment and remote patient management. India is developing home healthcare services across major urban centers as hospital groups, pharmacies, and specialized providers expand home-based treatment offerings. Terumo and JMS provide Asia with established regional expertise in infusion and vascular-access technologies.

• Middle East & Africa

Middle East & Africa represents 5.0% of the global home infusion therapy market within the regional framework used in this report. Adoption remains concentrated around major metropolitan healthcare centers, private hospitals, specialty pharmacies, and expanding home healthcare providers. Gulf countries are investing in healthcare modernization, digital health systems, specialized treatment centers, and patient-centered delivery models, creating opportunities for portable infusion technologies.

Saudi Arabia's population exceeded 35 million in 2024, supporting expanding requirements for chronic disease management and healthcare infrastructure. The United Arab Emirates is also developing home healthcare capabilities through private healthcare groups and technology-enabled patient services. Across Africa, market penetration remains comparatively limited because nursing availability, reimbursement, healthcare access, and supply-chain infrastructure vary substantially. South Africa maintains relatively stronger private healthcare capabilities. Increasing urbanization and expansion of private medical services are gradually improving opportunities for infusion pumps, intravenous sets, vascular-access devices, nutritional therapies, and specialty pharmaceutical administration.

• Rest of the World

Rest of the World holds 4.0% of the global home infusion therapy market, completing the regional distribution at exactly 100%. This category primarily captures markets across Latin America and other territories not included within the principal regional classifications. Brazil, Mexico, Argentina, and selected developing healthcare markets are expanding home healthcare availability as private hospital systems, insurers, pharmacies, and medical technology distributors strengthen decentralized care capabilities.

Brazil has a population exceeding 200 million, creating a substantial potential patient base for chronic disease management and post-acute healthcare services. Market development nevertheless depends heavily on insurance coverage, affordability, nursing capacity, logistics, and reliable access to infusion equipment. Multinational manufacturers frequently serve these markets through regional distributors and hospital partnerships. Growing adoption of portable pumps, specialty pharmaceuticals, nutritional therapies, and remote healthcare technologies is supporting gradual expansion of home infusion capabilities across major urban healthcare networks.

KEY INDUSTRY PLAYERS

The home infusion therapy market includes multinational medical technology manufacturers, specialized infusion equipment developers, vascular-access companies, and pharmaceutical delivery specialists. Baxter, B. Braun, Fresenius Kabi, Terumo, ICU Medical, JMS, Caesarea Medical Electronics, CareFusion, and Smiths Medical have established positions through infusion pumps, administration sets, connectors, cannulas, and related technologies. Competitive strategies increasingly emphasize connected devices, ambulatory pump platforms, dose accuracy, safety systems, product interoperability, and international distribution. Partnerships with hospitals, specialty pharmacies, distributors, and home healthcare providers strengthen market reach. Companies are also prioritizing compact designs and digital capabilities as decentralized treatment becomes more technologically sophisticated.

List of Top Home Infusion Therapy Companies

• Baxter
• Caesarea Medical Electronics
• B. Braun Melsungen AG
• CareFusion Corporation
• ICU Medical Inc.
• Fresenius Kabi AG
• JMS Co. Ltd
• Terumo Corporation
• Smiths Medical

 Top Two Companies Market Share

• Baxter: Holds an estimated 14.8% competitive share through infusion systems, administration products, nutritional therapies, and global distribution capabilities.

• B. Braun Melsungen AG: Accounts for approximately 12.6% competitive share, supported by infusion pumps, vascular-access products, and administration systems.

Investment Analysis and Opportunities

Investment activity in the home infusion therapy market increasingly targets ambulatory infusion systems, specialty pharmacy infrastructure, digital monitoring, nursing networks, and home delivery logistics. Infusion pumps account for 49.6% of product demand, making portable and connected systems a particularly important investment category. Companies can also pursue opportunities in specialty pharmaceutical administration, biologics, nutritional support, and post-discharge anti-infective programs. Investors are prioritizing platforms that integrate pharmacy preparation, equipment, nursing, logistics, and digital patient engagement. Expansion into Asia provides additional opportunities because the region currently represents 21.0% of global market activity while healthcare infrastructure and home-based treatment availability continue developing.

New Product Development

New product development in the home infusion therapy market emphasizes portability, connectivity, safety, simplified programming, and accurate drug delivery. Infusion pumps, representing 49.6% of product demand, remain a major innovation focus as manufacturers develop lighter ambulatory systems with improved batteries, alarms, interfaces, and monitoring capabilities. Needleless connectors are also evolving through designs intended to improve disinfection and reduce unnecessary manipulation of intravenous lines. Connected platforms can transmit treatment information to clinical teams, supporting remote supervision and adherence management. Product developers are additionally addressing specialty pharmaceuticals through devices capable of handling complex administration protocols while improving usability for patients, caregivers, pharmacists, and home infusion nurses.

Home Infusion Therapy Five Recent Developments (2025–2026)

• February 2026 – BaxterExpanded digital infusion capabilities strengthen connected medication delivery across decentralized healthcare environments. ays.

• January 2026  ICU Medical – Advanced infusion platform development strengthens connected therapy management and medication delivery capabilities. 

• November 2025 B. Braun – Enhanced infusion technology portfolio supports safer ambulatory and home-based medication administration workflows. 

• September 2025Fresenius Kabi – Expanded infusion and nutrition capabilities support complex therapies outside traditional hospital environments. 

• June 2025 Terumo Corporation – Strengthened vascular-access technologies improve infusion safety and patient-centered treatment delivery capabilities. 

Home Infusion Therapy Market Report Coverage

The home infusion therapy market report covers product technologies, clinical applications, regional performance, competitive positioning, investment activity, innovation, and recent industry developments. Product analysis evaluates infusion pumps, intravenous sets, IV cannulas, and needleless connectors, with infusion pumps maintaining 49.6% share. Application coverage includes anti-infectives, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and others. Regional analysis evaluates North America, Europe, Asia, Middle East & Africa, and Rest of the World, with their allocated shares totaling exactly 100%. Competitive coverage examines major manufacturers, technology strategies, distribution positioning, connected infusion systems, patient safety developments, partnerships, and emerging home healthcare opportunities.